19 November 2017
News and Views
Links and Services
Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C, reports November's issue of Liver International.
International guidelines and routine clinical practice express concerns about antiviral treatment
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors